Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 31, Issue 5, 2010, Pages 533-539

  Minamiya, Yoshihiro ^a   Ono, Takashi ^b   Saito, Hajime ^b   Takahashi, Naoko ^b   Ito, Manabu ^b   Motoyama, Satoru ^b   Ogawa, Junichi ^b  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 78049509611     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0066-0     Document Type: Article

References (0)